home / stock / kura / kura news


KURA News and Press, Kura Oncology Inc. From 05/25/23

Stock Information

Company Name: Kura Oncology Inc.
Stock Symbol: KURA
Market: NASDAQ
Website: kuraoncology.com

Menu

KURA KURA Quote KURA Short KURA News KURA Articles KURA Message Board
Get KURA Alerts

News, Short Squeeze, Breakout and More Instantly...

KURA - How To Trade Kura Oncology Inc. Common Stock $KURA

2023-05-25 16:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

KURA - Kura Oncology Inc. Common Stock $KURA Investment Analysis and Advice

2023-05-16 00:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

KURA - Kura Oncology, Inc. (KURA) Q1 2023 Earnings Call Transcript

2023-05-10 22:13:10 ET Kura Oncology, Inc. (KURA) Q1 2023 Earnings Conference Call May 10, 2023, 17:00 ET Company Participants Pete De Spain - SVP, IR & Corporate Communications Troy Wilson - Chairman, CEO & President Thomas Doyle - SVP, Finance & Acc...

KURA - Kura Oncology GAAP EPS of -$0.50 beats by $0.04

2023-05-10 16:34:08 ET Kura Oncology press release ( NASDAQ: KURA ): Q1 GAAP EPS of -$0.50 beats by $0.04 . $406 million in cash, equivalents and investments provide runway into fourth quarter of 2025 For further details see: Kura Oncology GAAP EPS of -$0.50 ...

KURA - Kura Oncology Reports First Quarter 2023 Financial Results

– Evolving data from Phase 1 trial of ziftomenib in NPM1-mutant AML to be presented at EHA – – Site activation and enrollment in Phase 2 registration-directed trial of ziftomenib in NPM1-mutant AML outperforming projections – – First combination study ...

KURA - Kura Oncology to Participate in JMP Securities Life Sciences Conference

SAN DIEGO, May 09, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced its participation in the JMP Securities Life Sciences Conference in New...

KURA - Kura Oncology to Report First Quarter 2023 Financial Results

SAN DIEGO, May 03, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it will report first quarter 2023 financial results after the clos...

KURA - 3 Under-the-Radar Stocks That AI Predicts Will Soar in May

2023-05-01 14:07:12 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors looking for help finding the best under-the-radar stocks may have a new ally: the AI chatbot. Using the prompt “ publicly traded companies that may be on the cusp of ...

KURA - When Kura Oncology Inc. Common Stock ($KURA) Moves Investors should Listen

2023-04-26 16:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

KURA - Catalyst watch: Earnings blitz, Mobileye lockup expiration and the new one-day VIX debut

2023-04-21 15:00:36 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar ...

Previous 10 Next 10